Cefamandole - CAS 34444-01-4
Catalog number: 34444-01-4
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Cefamandole is is the formate ester cefamandole nafate, a second-generation broad-spectrum cephalosporin antibiotic. It releases free NMTT, which can cause hypoprothrombinemia.
White powder
(6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid; (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct
Soluble in DMSO
Store at -20 °C
A broad-spectrum cephalosporin antibiotic
Quality Standard:
Enterprise Standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
1.75 g/cm3
Canonical SMILES:
Current Developer:
Eli Lilly Canada Inc
1.Development of a Novel Chromogenic Medium for Improved Campylobacter Detection from Poultry Samples.
Teramura H1, Iwasaki M2, Ogihara H3. J Food Prot. 2015 Sep;78(9):1750-5. doi: 10.4315/0362-028X.JFP-15-115.
The presence of expanded-spectrum β-lactamase (ESBL)-producing Escherichia coli is a common problem in the isolation of Campylobacter from poultry samples using conventional cefoperazone-based selective media. A novel chromogenic medium (CM-HT), based on modified charcoal cefoperazone deoxycholate agar (mCCDA), has been developed as a solution for improved Campylobacter detection from poultry samples. Although the basic components of CM-HT are the same as mCCDA, CM-HT uses both granular charcoal and sodium cefoxitin to enhance viewability and inhibit ESBL-producing bacteria. All tested Campylobacter jejuni (n = 31) and Campylobacter coli (n = 6) strains grew and formed purple-colored colonies on CM-HT. In contrast, the growth of all other tested microorganisms, including ESBL-producing E. coli strains, was suppressed by this medium. Additionally, 84 poultry samples were examined for the presence of Campylobacter using the ISO 10272-1 method (enrichment with Bolton broth) and the NIHSJ-02 method (enrichment with Preston broth) with mCCDA and CM-HT media for the isolation.
2.Restoring the selectivity of modified charcoal cefoperazone deoxycholate agar for the isolation of Campylobacter species using tazobactam, a β-lactamase inhibitor.
Smith S1, Meade J1, McGill K1, Gibbons J1, Bolton D2, Whyte P3. Int J Food Microbiol. 2015 Oct 1;210:131-5. doi: 10.1016/j.ijfoodmicro.2015.06.014. Epub 2015 Jun 23.
Extended spectrum β-lactamase (ESBL) producing Escherichia coli have emerged as a contaminant on modified charcoal cefoperazone deoxycholate agar (mCCDA) when attempting to selectively isolate Campylobacter spp. from poultry. E. coli are particularly problematic given their ability to grow under microaerophilic conditions and have been shown to outcompete Campylobacter species making Campylobacter detection or enumeration difficult. This paper recommends a novel method for restoring the selectivity of mCCDA using tazobactam, a β-lactamase inhibitor. The method significantly inhibited ESBL E. coli growth in spiked or naturally contaminated broiler caecal samples (p≤0.01) when compared to conventional mCCDA. This effect was seen at concentrations as low as 1mg/L tazobactam. TmCCDA(1) was found to inhibit up to 8 log10 CFU/mL of ESBL E. coli in mixed pure cultures and 7.5 log10 CFU/mL in caecal samples. Furthermore TmCCDA concentrations up to 10 mg/L had no statistically significant inhibitory effect (p≥0.
3.Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy.
Wang Q1, Wu Y1, Chen B2, Zhou J1. BMC Anesthesiol. 2015 Mar 13;15:33. doi: 10.1186/s12871-015-0012-1. eCollection 2015.
BACKGROUND: To identify changes in cefoperazone/sulbactam penetration into cerebrospinal fluid (CSF) after craniotomy and to investigate preliminarily whether cefoperazone/sulbactam CSF concentration can reach therapeutic level when administered intravenously after neurosurgical operation.
4.Achromobacter respiratory infections.
Swenson CE1, Sadikot RT. Ann Am Thorac Soc. 2015 Feb;12(2):252-8. doi: 10.1513/AnnalsATS.201406-288FR.
Achromobacteria are ubiquitous environmental organisms that may also become opportunistic pathogens in certain conditions, such as cystic fibrosis, hematologic and solid organ malignancies, renal failure, and certain immune deficiencies. Some members of this genus, such as xylosoxidans, cause primarily nosocomially acquired infections affecting multiple organ systems, including the respiratory tract, urinary tract, and, less commonly, the cardiovascular and central nervous systems. Despite an increasing number of published case reports and literature reviews suggesting a global increase in achromobacterial disease, most clinicians remain uncertain of the organism's significance when clinically isolated. Moreover, effective treatment can be challenging due to the organism's inherent and acquired multidrug resistance patterns. We reviewed all published cases to date of non-cystic fibrosis achromobacterial lung infections to better understand the organism's pathogenic potential and drug susceptibilities.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Antibacterial Products

CAS 16773-42-5 Ornidazole

(CAS: 16773-42-5)

Ornidazole is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria.

CAS 4697-36-3 Carbenicillin

(CAS: 4697-36-3)

Carbenicillin is broad-spectrum semisynthetic penicillin derivative used parenterally. It is a semi-synthetic penicillin antibiotic which interferes with cell w...

CAS 24356-60-3 Cephapirin Sodium

Cephapirin Sodium
(CAS: 24356-60-3)

Cephapirin is a cephalosporin antibiotic agent.

CAS 15176-29-1 Edoxudine

(CAS: 15176-29-1)

Edoxudine, synthesised via organopalladium intermediates, is an antiviral drug.

CAS 116-43-8 Succinylsulfathiazole

(CAS: 116-43-8)

Succinylsulfathiazole, a sulfonamide derivative, could restrain the bacteria in the intestine to block the production of folic acid.

Dextrorotation nimorazole phosphate este
(CAS: 1124347-33-6)

The organic phosphate form of Dextrorotary morpholine ornidazole, an effective anti-parasitic agent, has been found to have better tolerance as one of the fourt...

CAS 98-96-4 Pyrazinamide

(CAS: 98-96-4)

Pyrazinamide is a pyrazine that is used therapeutically as an antitubercular agent. It is a prodrug that stops the growth of Mycobacterium tuberculosis. It was ...

CAS 53003-10-4 Salinomycin

(CAS: 53003-10-4)

Salinomycin is an antibacterial and coccidiostat ionophore therapeutic drug. The mechanism of action by which salinomycin kills cancer stem cells specifically r...

Chemical Structure

CAS 34444-01-4 Cefamandole

Quick Inquiry

Verification code

Featured Items